Rovi Pharma Industrial Services, S.A.

Poland

All drugs from this manufacturer

  • CRUSIA

    Crusia is used to treat existing blood clots and to prevent the formation of new ones. It is also used after surgical procedures, in the course of certain diseases (e.g., cancer or unstable angina pectoris), after a myocardial infarction, and to prevent the formation of clots in dialyzer tubing.

    Dosage form: solution for injection in ampoule-syringe

    Active substance Dosage
    sodium enoxaparin 100 mg/ml

    ATC: B01AB05

  • The medicine is used to treat existing blood clots and to prevent the formation of new ones. It may be used, among other things, before and after surgery, during acute illness with limited mobility, in the case of cancer-induced clots, in unstable angina pectoris, after a myocardial infarction, and to prevent blood clotting in dialyzer tubing.

    Dosage form: solution for injection in ampoule-syringe

    Active substance Dosage
    sodium enoxaparin 150 mg/ml

    ATC: B01AB05

  • Crusia is used to treat existing blood clots and to prevent the formation of new ones. It is prescribed, among other things, in the case of surgical procedures, diseases that limit mobility, cancers, unstable angina pectoris, after myocardial infarction, and to prevent blood clotting in dialyzer tubing.

    Dosage form: solution for injection in ampoule-syringe

    Active substance Dosage
    enoxaparin sodium 120 mg/0.8 ml

    ATC: B01AB05

  • The medicine is used to treat existing blood clots and to prevent the formation of new ones. It is used, among other things, before and after surgery, in the course of diseases that limit mobility, in the case of clots caused by cancer, in unstable angina pectoris, after a myocardial infarction, and to prevent clots in dialyzer tubing.

    Dosage form: solution for injection in ampoule-syringe

    Active substance Dosage
    sodium enoxaparin 80 mg/0.8 ml

    ATC: B01AB05

  • The medicine is used to treat existing blood clots (it prevents them from growing and helps the body dissolve them) and to prevent the formation of new clots. It may be used, among other things, before and after surgery, during acute illness with limited mobility, in the case of cancer-induced clots, in unstable angina pectoris, after a myocardial infarction, and to prevent clots in dialyzer tubing.

    Dosage form: solution for injection in ampoule-syringe

    Active substance Dosage
    sodium enoxaparin 60 mg/0.6 ml

    ATC: B01AB05

  • The medicine is used to treat existing blood clots and to prevent the formation of new ones. It is used, among other things, before and after surgical procedures, during acute illness with limited mobility, in the case of clots caused by cancer, in unstable angina pectoris, after a myocardial infarction, and to prevent clots in dialyzer tubing.

    Dosage form: solution for injection in ampoule-syringe

    Active substance Dosage
    sodium enoxaparin 40 mg/0.4 ml

    ATC: B01AB05

  • The medicine is used to treat existing blood clots and to prevent the formation of new ones. It is also used to prevent clots after surgery, during certain diseases, after a myocardial infarction, in unstable angina pectoris, and in patients undergoing dialysis.

    Dosage form: solution for injection in ampoule-syringe

    Active substance Dosage
    sodium enoxaparin 20 mg/0.2 ml

    ATC: B01AB05

  • The medicine is used to treat existing blood clots and to prevent the formation of new ones. It may be used before and after surgery, during acute illness with limited mobility, in cancer patients, in unstable angina pectoris, after a myocardial infarction, and to prevent clots in dialyzer tubing.

    Dosage form: solution for injection in ampoule-syringe

    Active substance Dosage
    sodium enoxaparin 20 mg/0.2 ml

    ATC: B01AB05

  • The medicine is used to treat existing blood clots and to prevent the formation of new ones. It is used, among other things, before and after surgical procedures, during acute illness with limited mobility, in cancerous diseases, in unstable angina pectoris, after a myocardial infarction, and to prevent clots in dialyzer tubing.

    Dosage form: solution for injection in ampoule-syringe

    Active substance Dosage
    sodium enoxaparin 80 mg/0.8 ml

    ATC: B01AB05

  • Losmina is used to treat existing blood clots and to prevent the formation of new ones. It is prescribed, among other things, before and after surgical procedures, during acute illness with limited mobility, in cancerous diseases, in unstable angina pectoris, after a myocardial infarction, and to prevent clots in dialyzer tubing.

    Dosage form: solution for injection in ampoule-syringe

    Active substance Dosage
    sodium enoxaparin 100 mg/ml

    ATC: B01AB05

  • The medicine is used to treat existing blood clots and to prevent the formation of new ones. It is prescribed, among other things, before and after surgical procedures, during acute illness involving restricted mobility, in cases of cancer, in unstable angina pectoris, after a myocardial infarction, and to prevent clotting in dialyzer tubing.

    Dosage form: solution for injection in ampoule-syringe

    Active substance Dosage
    enoxaparin sodium 150 mg/ml

    ATC: B01AB05

  • The medicine is used to treat existing blood clots and to prevent the formation of new ones. It may be used, among other things, before and after surgery, during acute illness with limited mobility, in cancerous diseases, in unstable angina pectoris, after a myocardial infarction, and to prevent clotting in dialyzer tubing.

    Dosage form: solution for injection in ampoule-syringe

    Active substance Dosage
    enoxaparin sodium 120 mg/0.8 ml

    ATC: B01AB05

  • Losmina is used to treat existing blood clots and to prevent the formation of new ones. It is used, among other things, before and after surgery, during acute illness with limited mobility, in patients with cancer, in unstable angina pectoris, after a myocardial infarction, and to prevent clots in dialyzer tubing.

    Dosage form: solution for injection in ampoule-syringe

    Active substance Dosage
    sodium enoxaparin 60 mg/0.6 ml

    ATC: B01AB05

  • The medicine is used to treat existing blood clots and to prevent the formation of new ones. It is used, among others, before and after surgery, during acute illness with limited mobility, in cancerous diseases, in unstable angina pectoris, after a myocardial infarction, and to prevent clots in dialyzer tubing.

    Dosage form: solution for injection in ampoule-syringe

    Active substance Dosage
    sodium enoxaparin 40 mg/0.4 ml

    ATC: B01AB05